Genetic risk score based on obesity-related genes and progression in weight loss after bariatric surgery

Background: Obesity is a polygenic multifactorial disease. Recent genome-wide association studies have identified several common loci associated with obesity-related phenotypes. Bariatric surgery (BS) is the most effective long-term treatment for patients with severe obesity. The huge variability in...

Descripción completa

Detalles Bibliográficos
Autores: Mas-Bermejo, Patricia|||0000-0003-4789-9650, Azcona-Granada, Natalia, Peña, Elionora, Lecube, Albert|||0000-0001-9684-0183, Ciudin, Andreea|||0000-0001-5622-0203, Simó Canonge, Rafael|||0000-0003-0475-3096, Luna, Alexis|||0000-0003-2351-5819, Rigla Cros, Mercedes|||0000-0002-6691-4871, Arenas Solà, Concepción|||0000-0002-6489-4934, Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189, Rosa de la Cruz, Araceli|||0000-0001-6935-3785
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:324537
Acceso en línea:https://ddd.uab.cat/record/324537
https://dx.doi.org/urn:doi:10.1016/j.soard.2024.04.002
Access Level:acceso abierto
Palabra clave:Bariatric surgery
Genetic risk score
Long-term follow-up
Obesity
Weight loss
SDG 3 - Good Health and Well-being
Descripción
Sumario:Background: Obesity is a polygenic multifactorial disease. Recent genome-wide association studies have identified several common loci associated with obesity-related phenotypes. Bariatric surgery (BS) is the most effective long-term treatment for patients with severe obesity. The huge variability in BS outcomes between patients suggests a moderating effect of several factors, including the genetic architecture of the patients. Objective: To examine the role of a genetic risk score (GRS) based on 7 polymorphisms in 5 obesity-candidate genes (FTO, MC4R, SIRT1, LEP, and LEPR) on weight loss after BS. Setting: University hospital in Spain. Methods: We evaluated a cohort of 104 patients with severe obesity submitted to BS (Roux-en-Y gastric bypass or sleeve gastrectomy) followed up for >60 months (lost to follow-up, 19.23%). A GRS was calculated for each patient, considering the number of carried risk alleles for the analyzed genes. During the postoperative period, the percentage of excess weight loss total weight loss and changes in body mass index were evaluated. Generalized estimating equation models were used for the prospective analysis of the variation of these variables in relation to the GRS. Results: The longitudinal model showed a significant effect of the GRS on the percentage of excess weight loss (P = 1.5 × 10-5), percentage of total weight loss (P = 3.1 × 10-8), and change in body mass index (P = 7.8 × 10-16) over time. Individuals with a low GRS seemed to experience better outcomes at 24 and 60 months after surgery than those with a higher GRS. Conclusion: The use of the GRS in considering the polygenic nature of obesity seems to be a useful tool to better understand the outcome of patients with obesity after BS.